TITAN: phase III study of doxorubicin/cyclophosphamide followed by ixabepilone or paclitaxel in early-stage triple-negative breast cancer.
about
TITAN: phase III study of doxorubicin/cyclophosphamide followed by ixabepilone or paclitaxel in early-stage triple-negative breast cancer.
description
2017 nî lūn-bûn
@nan
2017年の論文
@ja
2017年学术文章
@wuu
2017年学术文章
@zh-cn
2017年学术文章
@zh-hans
2017年学术文章
@zh-my
2017年学术文章
@zh-sg
2017年學術文章
@yue
2017年學術文章
@zh
2017年學術文章
@zh-hant
name
TITAN: phase III study of doxo ...... triple-negative breast cancer.
@ast
TITAN: phase III study of doxo ...... triple-negative breast cancer.
@en
type
label
TITAN: phase III study of doxo ...... triple-negative breast cancer.
@ast
TITAN: phase III study of doxo ...... triple-negative breast cancer.
@en
prefLabel
TITAN: phase III study of doxo ...... triple-negative breast cancer.
@ast
TITAN: phase III study of doxo ...... triple-negative breast cancer.
@en
P2093
P2860
P1476
TITAN: phase III study of doxo ...... triple-negative breast cancer.
@en
P2093
Adam Brufsky
Brooke R Daniel
Caryn Silver
David R Drosick
Denise A Yardley
Donald S Gravenor
Edward R Arrowsmith
Fred Kudrik
Gladys I Rodriguez
Howard A Burris
P2860
P2888
P304
P356
10.1007/S10549-017-4285-6
P407
P577
2017-05-15T00:00:00Z